Pricing Log in Create free account

Biotricity Inc. (BTCY) vs HeartSciences Inc. (HSCS)

Biotricity Inc. and HeartSciences Inc. are both Medical Devices companies. HeartSciences Inc. is the larger, with a market value of $13.3M against $10.9M — 1.2× the size. HeartSciences Inc. grew revenue faster over the last twelve months: 131.9% against 13.4%. Biotricity Inc. has the higher net margin (−21.0% vs −48,621.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Biotricity Inc. leads on 13 and HeartSciences Inc. on 3.

Valuation

Metric BTCY HSCS Medical Devices median
P/E n/m n/m 24.94
P/S 0.08 488.61 2.66
P/B n/m n/m 2.36
Price to free cash flow 10.51 n/m 28.12
EV/EBITDA 11.61 n/m 11.42
EV/Sales 1.68 519.02 2.76
Earnings yield (233.33%) (114.59%) (12.66%)
Free cash flow yield 9.51% (69.02%) (7.18%)

Profitability

Metric BTCY HSCS Medical Devices median
Gross margin 81.47% 18.01% 57.76%
Operating margin 9.56% (44,918.48%) (14.84%)
Net margin (21.00%) (48,621.80%) (14.45%)
Free cash flow margin 0.99% (33,725.12%) (5.70%)
Return on equity 9.75% (1,854.69%) (10.56%)
Return on assets (57.12%) (201.67%) (17.26%)
Return on invested capital 0.00% 0.00% (5.22%)

Growth

Metric BTCY HSCS Medical Devices median
Revenue growth (TTM) 13.41% 131.87% 10.41%
EPS growth (last fiscal year) 80.00% 62.74% 28.17%
Revenue growth, 5-year CAGR 36.43% (30.01%) 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BTCY HSCS Medical Devices median
Debt to equity (0.75) 0.00 0.04
Current ratio 0.15 0.14 2.67
Net debt to EBITDA 10.85 0.21 0.54

Dividend

Metric BTCY HSCS Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric BTCY HSCS Medical Devices median
Market cap 10.87m 13.26m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack